Literature DB >> 2297909

Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints.

G R Warnick1, R H Knopp, V Fitzpatrick, L Branson.   

Abstract

We compared low-density lipoprotein cholesterol (LDL) values obtained by the Friedewald formula--i.e., total cholesterol minus high-density lipoprotein (HDL) cholesterol minus very-low-density lipoprotein (VLDL) cholesterol (estimated as triglyceride divided by 5)--with those obtained by lipoprotein fractionation, using 4736 specimens. When triglycerides were less than 2.0 g/L, greater than 90% of estimated LDL cholesterol values were acceptable, within +/- 10% of measured values. At triglyceride concentrations of 2.0-4.0 g/L and 4.0-6.0 g/L, only 72% and 39%, respectively, of the estimates were acceptable. LDL values derived from an alternative formula, estimating VLDL as triglycerides divided by 6, were even less accurate. Nevertheless, the use of estimated LDL for risk classification based on the National Cholesterol Education Program Adult Treatment Panel cutpoints of 1.30 and 1.60 g/L was considered acceptable. At triglyceride concentrations less than or equal to 5.0 g/L, 88% of classifications based on estimated LDL (using triglycerides divided by 5) were concordant with those by measured LDL. Eleven percent of classifications were shifted across one cutpoint, evenly distributed between high and low. Fewer than 1% of classifications, all with Type III hyperlipoproteinemia, were misclassified two cutpoints high. Refinements in the estimation model did not substantially improve LDL estimation or concordance of risk classification.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297909

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  138 in total

1.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

2.  Prevalence of abnormal lipid and blood pressure values among an ethnically diverse population of eighth-grade adolescents and screening implications.

Authors:  Russell Jago; Joanne S Harrell; Robert G McMurray; Sharon Edelstein; Laure El Ghormli; Stanley Bassin
Journal:  Pediatrics       Date:  2006-06       Impact factor: 7.124

3.  Number of teeth, C-reactive protein, fibrinogen and cardiovascular mortality: a 15-year follow-up study in a Finnish cohort.

Authors:  Sok-Ja Janket; Alison E Baird; Judith A Jones; Elizabeth A Jackson; Markku Surakka; Wen Tao; Jukka H Meurman; Thomas E Van Dyke
Journal:  J Clin Periodontol       Date:  2013-12-10       Impact factor: 8.728

4.  Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPIC-Potsdam study.

Authors:  S Jacobs; K Schiller; E Jansen; A Fritsche; C Weikert; R di Giuseppe; H Boeing; M B Schulze; J Kröger
Journal:  Eur J Clin Nutr       Date:  2014-02-26       Impact factor: 4.016

5.  Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen.

Authors:  N I Ntukidem; A T Nguyen; V Stearns; M Rehman; A Schott; T Skaar; Y Jin; P Blanche; L Li; S Lemler; J Hayden; R M Krauss; Z Desta; D A Flockhart; D F Hayes
Journal:  Clin Pharmacol Ther       Date:  2007-08-22       Impact factor: 6.875

6.  Lipid targets in clinical practice: successes, failures and lessons to be learned.

Authors:  M Dunne; O Mac Ananey; C Markham; V Maher
Journal:  Ir J Med Sci       Date:  2013-04-25       Impact factor: 1.568

7.  Evaluation of different formulas for LDL-C calculation.

Authors:  Ana Vujovic; Jelena Kotur-Stevuljevic; Slavica Spasic; Nada Bujisic; Jelena Martinovic; Milica Vujovic; Vesna Spasojevic-Kalimanovska; Aleksandra Zeljkovic; Dragoljub Pajic
Journal:  Lipids Health Dis       Date:  2010-03-10       Impact factor: 3.876

8.  Rethink Organization to iMprove Education and Outcomes (ROMEO): a multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes.

Authors:  Marina Trento; Silvia Gamba; Luigi Gentile; Giorgio Grassi; Valerio Miselli; Gabriel Morone; Pietro Passera; Laura Tonutti; Marco Tomalino; Piervincenzo Bondonio; Franco Cavallo; Massimo Porta
Journal:  Diabetes Care       Date:  2010-01-26       Impact factor: 17.152

9.  Geographical variation in cardiovascular incidence: results from the British Women's Heart and Health Study.

Authors:  Lois G Kim; Claire Carson; Debbie A Lawlor; Shah Ebrahim
Journal:  BMC Public Health       Date:  2010-11-15       Impact factor: 3.295

10.  Olivopontocerebellar atrophy of neonatal onset and disialotransferrin developmental deficiency syndrome.

Authors:  S P Horslen; P T Clayton; B N Harding; N A Hall; G Keir; B Winchester
Journal:  Arch Dis Child       Date:  1991-09       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.